EUVIMEDObjevte EUVIMED
Crossref

Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non‐alcoholic fatty liver disease

Yufeng Dai, Ruijie Xu, Jinxiang Chen, Jialong Fang, Hao Zhang, Haitao Li iD, Wei Chen

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16238 ↗

At a glance

Journal article in British Journal of Pharmacology, 2024. Written by Yufeng Dai and 6 co-authors. Institution: State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Insulin Resistance, Insulins. Cited 19 times so far (Crossref); 54 references. Funded by: Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province, the Jiangsu Specially-Appointed Professor Program, the National Youth 1000 Talents Plan.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose Defective insulin signalling and dysfunction of the endoplasmic reticulum (ER), driven by excessive lipid accumulation in the liver, is a characteristic feature in the pathogenesis of non‐alcoholic fatty liver disease (NAFLD). Thromboxane A 2 (TXA 2 ), an arachidonic acid metabolite, is significantly elevated in obesity and plays a crucial role in hepatic gluconeogenesis and adipose tissue macrophage polarization. However, the role of liver TXA 2 /TP receptors in insulin resistance and lipid metabolism is largely unknown. Experimental Approach TP receptor knockout (TP −/− ) mice were generated and fed a high‐fat diet for 16 weeks. Insulin sensitivity, ER stress responses and hepatic lipid accumulation were assessed. Furthermore, we used primary hepatocytes to dissect the mechanisms by which the TXA 2 /TP receptor axis regulates insulin signalling and hepatocyte lipogenesis. Key Results TXA 2 was increased in diet‐induced obese mice, and depletion of TP receptors in adult mice improved systemic insulin resistance and hepatic steatosis. Mechanistically, we found that the TXA 2 /TP receptor axis disrupts insulin signalling by activating the Ca 2+ /calcium calmodulin‐dependent kinase II γ (CaMKIIγ)–protein kinase RNA‐like endoplasmic reticulum kinase (PERK)–C/EBP homologous protein (Chop)–tribbles‐like protein 3 (TRB3) axis in hepatocytes. In addition, our results revealed that the TXA 2 /TP receptor axis directly promoted lipogenesis in primary hepatocytes and contributed to Kupffer cell inflammation. Conclusions and Implications The TXA 2 /TP receptor axis facilitates insulin resistance through Ca 2+ /CaMKIIγ to activate PERK–Chop–TRB3 signalling. Inhibition of hepatocyte TP receptors improved hepatic steatosis and inflammation. The TP receptor is a new therapeutic target for NAFLD and metabolic syndrome.

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseaseInsulin ResistanceInsulinsAnimalsMiceReceptors, Thromboxane A2, Prostaglandin H2Thromboxane A2Calcium-Calmodulin-Dependent Protein Kinase Type 2LiverHepatocytesInflammationEndoplasmic Reticulum StressDiet, High-FatMice, Inbred C57BL

Author keywords

CaMKIIγER stressNAFLDTXA2hepatic insulin resistance

Substances

Receptors, Thromboxane A2, Prostaglandin H2Thromboxane A2Calcium-Calmodulin-Dependent Protein Kinase Type 2Insulins

Authors and institutions

  • State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.
  • School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
  • National Engineering Research Center for Functional Food, Jiangnan University, Wuxi, Jiangsu, China.

ORCID profiles: Haitao Li

Funding

  • Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province
  • the Jiangsu Specially-Appointed Professor Program
  • the National Youth 1000 Talents Plan
  • National Natural Science Foundation of China
  • Thousand Young Talents Program of China
  • Jiangsu Province Recruitment Plan for High-level, Innovative and Entrepreneurial Talents (Innovative Research Team)

Cite

APA

Dai, Y., Xu, R., Chen, J., Fang, J., Zhang, H., Li, H., & Chen, W. (2024). Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non‐alcoholic fatty liver disease. British Journal of Pharmacology. https://doi.org/10.1111/bph.16238

Vancouver

Dai Y, Xu R, Chen J, Fang J, Zhang H, Li H, et al. Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non‐alcoholic fatty liver disease. British Journal of Pharmacology. 2024. doi:10.1111/bph.16238

BibTeX
@article{Dai2024,
  author = {Dai, Yufeng and Xu, Ruijie and Chen, Jinxiang and Fang, Jialong and Zhang, Hao and Li, Haitao and Chen, Wei},
  title = {Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non‐alcoholic fatty liver disease},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16238}
}
Start for free →